Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 29,813 | 32,494 | 34,056 | 37,219 | 42,131 |
| Receivables | 550 | 1,207 | 956 | 716 | N/A |
| TOTAL | $32,205 | $35,761 | $37,236 | $40,178 | $44,896 |
| Non-Current Assets | |||||
| PPE Net | 252 | 305 | 338 | 342 | 378 |
| Other Non-Current Assets | 157 | 213 | 267 | 320 | 373 |
| TOTAL | $409 | $518 | $605 | $662 | $751 |
| Total Assets | $32,614 | $36,279 | $37,841 | $40,840 | $45,647 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,806 | 1,421 | 2,937 | 976 | 1,378 |
| TOTAL | $1,924 | $1,587 | $3,145 | $1,216 | $1,619 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 10 | 27 | 57 | 119 |
| TOTAL | $N/A | $10 | $27 | $57 | $119 |
| Total Liabilities | $1,924 | $1,597 | $3,172 | $1,273 | $1,738 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,174 | 10,174 | 10,174 | 8,143 | 8,143 |
| Common Shares | 10 | 10 | 8 | 8 | 8 |
| Retained earnings | -311,450 | -307,285 | -303,119 | -297,930 | -293,429 |
| TOTAL | $30,690 | $34,682 | $34,669 | $39,567 | $43,909 |
| Total Liabilities And Equity | $32,614 | $36,279 | $37,841 | $40,840 | $45,647 |